Cost-effectiveness of thiopurine methyltransferase genotype screening in IBD

被引:8
作者
Kitiyakara, T [1 ]
Hayat, J [1 ]
McIntyre, AS [1 ]
机构
[1] Wycombe Hosp, Dept Gastroenterol, High Wycombe, Bucks, England
关键词
D O I
10.1111/j.1365-2036.2005.02358.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:790 / 791
页数:3
相关论文
共 7 条
[1]   Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy [J].
Colombel, JF ;
Ferrari, N ;
Debuysere, H ;
Marteau, P ;
Gendre, JP ;
Bonaz, B ;
Soulé, JC ;
Modgliani, R ;
Touze, Y ;
Catala, P ;
Libersa, C ;
Broly, F .
GASTROENTEROLOGY, 2000, 118 (06) :1025-1030
[2]   Review article: monitoring for drug side-effects in inflammatory bowel disease [J].
Cunliffe, RN ;
Scott, BB .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (04) :647-662
[3]  
Hanauer SB, 2001, AM J GASTROENTEROL, V96, P635
[4]   PHARMACOGENETICS OF ACUTE AZATHIOPRINE TOXICITY - RELATIONSHIP TO THIOPURINE METHYLTRANSFERASE GENETIC-POLYMORPHISM [J].
LENNARD, L ;
VANLOON, JA ;
WEINSHILBOUM, RM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :149-154
[5]   Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease:: impact of thiopurine S-methyltransferase polymorphism [J].
Schwab, M ;
Schäffeler, E ;
Marx, C ;
Fischer, C ;
Lang, T ;
Behrens, C ;
Gregor, M ;
Eichelbaum, M ;
Zanger, UM ;
Kaskas, BA .
PHARMACOGENETICS, 2002, 12 (06) :429-436
[6]   Frequency of use and standards of care for the use of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease: A systematic review of the literature and a survey of Canadian gastroenterologists [J].
Wallace, TM ;
van Zanten, SJOV .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 15 (01) :21-28
[7]   Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease [J].
Winter, J ;
Walker, A ;
Shapiro, D ;
Gaffney, D ;
Spooner, RJ ;
Mills, PR .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (06) :593-599